VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | Treatment strategies for high-risk MM

VJHemOnc is committed to improving our service to you

Jesús San Miguel

Jesus San Miguel, MD, Universidad de Navarra, Navarra, discusses treatment strategies for high-risk multiple myeloma patients, including immunotherapeutic options, such as monoclonal antibodies, bispecific antibodies and CAR T-cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter